Kim HR, Kang HN, Yun MR, Ju KY, et al. Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck. Br J Cancer 2020;123:1720-1729.
PMID: 32963347